Pitofsky Jason 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.REGN，2026/11/6 申報
- 申報編號
- 0002009236-26-000003
- 申報時間
- 2026/11/6 16:01 ET
- 交易日
- 2026/11/4
- 申報延遲
- 2 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 11 筆非衍生性交易、3 筆衍生性交易。公開市場賣出合計 $382.7 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Pitofsky JasonCIK 0002009236 | 高階主管（SVP Controller） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/11/4 | Common Stock | M行使選擇權取得 | +1,500 | $726.53 | +$1,089,795 | 5,772 | 直接 | |
| 2026/11/4 | Common Stock | M行使選擇權取得 | +1,478 | $644.54 | +$952,630.12 | 7,250 | 直接 | |
| 2026/11/4 | Common Stock | M行使選擇權取得 | +905 | $492.00 | +$445,260 | 8,155 | 直接 | |
| 2026/11/4 | Common Stock | S賣出處分 | −439 | $939.57F1 | −$412,471.23 | 7,716 | 直接 | |
| 2026/11/4 | Common Stock | S賣出處分 | −575 | $940.46F2 | −$540,764.5 | 7,141 | 直接 | |
| 2026/11/4 | Common Stock | S賣出處分 | −982 | $941.58F3 | −$924,631.56 | 6,159 | 直接 | |
| 2026/11/4 | Common Stock | S賣出處分 | −1,215 | $942.31F4 | −$1,144,906.65 | 4,944 | 直接 | |
| 2026/11/4 | Common Stock | S賣出處分 | −529 | $943.53F5 | −$499,127.37 | 4,415 | 直接 | |
| 2026/11/4 | Common Stock | S賣出處分 | −108 | $944.22F6 | −$101,975.76 | 4,307 | 直接 | |
| 2026/11/4 | Common Stock | S賣出處分 | −35 | $945.61 | −$33,096.35 | 4,272 | 直接 | |
| 2026/11/4 | Common Stock | S賣出處分 | −179 | $950.76F7 | −$170,186.04 | 0 | 間接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/11/4 | Common Stock | M行使選擇權處分 | −905 | $0.00 | $0 | 0 | 直接 | |
| 2026/11/4 | Common Stock | M行使選擇權處分 | −1,478 | $0.00 | $0 | 500 | 直接 | |
| 2026/11/4 | Common Stock | M行使選擇權處分 | −1,500 | $0.00 | $0 | 2,478 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Represents volume-weighted average price of sales of 439 shares of Company stock on November 4, 2026 at prices ranging from $939.10 to $939.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F2
Represents volume-weighted average price of sales of 575 shares of Company stock on November 4, 2026 at prices ranging from $940.15 to $940.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 982 shares of Company stock on November 4, 2026 at prices ranging from $941.08 to $941.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 1,215 shares of Company stock on November 4, 2026 at prices ranging from $942.00 to $942.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 529 shares of Company stock on November 4, 2026 at prices ranging from $943.00 to $943.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 108 shares of Company stock on November 4, 2026 at prices ranging from $944.00 to $944.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents volume-weighted average price of sales of 179 shares of Company stock on November 4, 2026 at prices ranging from $950.45 to $950.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 4, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。